Skip to main content

Apellis Pharmaceuticals, Inc.

APLSDelisted May 14, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001492422

Apellis Pharmaceuticals, Inc. was delisted on May 14, 2026; its insiders filed their last Form 4 on May 14, 2026; 324 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q2 2023

Institutional positions in Apellis Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
317
+37 vs. Q1 2023
Shares held
106.6M
−3.79M (−3.4%) vs. Q1 2023
Total value
$9.71B
+$2.43B (+33.4%) vs. Q1 2023
New holders
69
100 more added
Sold out
32
120 more reduced

2 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting APLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 317 institutions
Q1 2021: 175 institutionsQ2 2021: 205 institutionsQ3 2021: 181 institutionsQ4 2021: 187 institutionsQ1 2022: 212 institutionsQ2 2022: 212 institutionsQ3 2022: 250 institutionsQ4 2022: 244 institutionsQ1 2023: 282 institutionsQ2 2023: 317 institutionsQ3 2023: 256 institutionsQ4 2023: 284 institutionsQ1 2024: 302 institutionsQ2 2024: 263 institutionsQ3 2024: 265 institutionsQ4 2024: 260 institutionsQ1 2025: 255 institutionsQ2 2025: 247 institutionsQ3 2025: 273 institutionsQ4 2025: 280 institutionsQ1 2026: 324 institutionsQ2 2026: 1 institution
Value heldQ2 2023: $9.71B
Q1 2021: $2.80BQ2 2021: $4.08BQ3 2021: $2.29BQ4 2021: $3.83BQ1 2022: $4.62BQ2 2022: $4.15BQ3 2022: $6.66BQ4 2022: $5.20BQ1 2023: $7.28BQ2 2023: $9.71BQ3 2023: $4.34BQ4 2023: $6.82BQ1 2024: $6.65BQ2 2024: $4.43BQ3 2024: $3.41BQ4 2024: $4.04BQ1 2025: $2.80BQ2 2025: $2.28BQ3 2025: $2.77BQ4 2025: $3.17BQ1 2026: $5.56BQ2 2026: $10.2K
Institutions holding APLS and their total value by quarter
QuarterHoldersValue
Q2 20261$10.2K
Q1 2026324$5.56B
Q4 2025280$3.17B
Q3 2025273$2.77B
Q2 2025247$2.28B
Q1 2025255$2.80B
Q4 2024260$4.04B
Q3 2024265$3.41B
Q2 2024263$4.43B
Q1 2024302$6.65B
Q4 2023284$6.82B
Q3 2023256$4.34B
Q2 2023317$9.71B
Q1 2023282$7.28B
Q4 2022244$5.20B
Q3 2022250$6.66B
Q2 2022212$4.15B
Q1 2022212$4.62B
Q4 2021187$3.83B
Q3 2021181$2.29B
Q2 2021205$4.08B
Q1 2021175$2.80B

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Apellis Pharmaceuticals, Inc.; share changes are against Q1 2023.

Institutions holding APLS in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Point72 Asset Management, L.P.1,239,361$112.9M0.39%−640,363−34.1%Reduced
Cormorant Asset Management, LP1,310,000$119.3M6.80%−50,000−3.7%Reduced
Geode Capital Management, LLC1,498,389$136.5M0.02%−339,890−18.5%Reduced
Boxer Capital, LLC1,576,000$143.6M6.66%00.0%Unchanged
Janus Henderson Group PLC1,776,905$161.9M0.10%−2,904,577−62.0%Reduced
JPMorgan Chase & Co1,786,982$162.8M0.02%+138,530+8.4%Added
Jennison Associates LLC1,970,603$179.5M0.15%−642,164−24.6%Reduced
State Street Corp2,283,085$208.0M0.01%−696,777−23.4%Reduced
Octagon Capital Advisors LP2,618,300$238.5M33.28%−631,700−19.4%Reduced
FMR LLC4,225,595$385.0M0.03%+2,100,158+98.8%Added
EcoR1 Capital, LLC5,451,647$496.6M13.10%00.0%Unchanged
T. Rowe Price Investment Management, Inc.5,638,875$513.7M0.35%−121,789−2.1%Reduced
BlackRock Inc.5,747,627$523.6M0.01%−1,907,824−24.9%Reduced
Wellington Management Group LLP6,664,275$607.1M0.12%−1,614,164−19.5%Reduced
Price T Rowe Associates Inc7,072,226$644.3M0.09%+2,482,186+54.1%Added
Vanguard Group Inc9,401,290$856.5M0.02%−127,654−1.3%Reduced
Avoro Capital Advisors LLC11,111,111$1.01B13.73%00.0%Unchanged
Cercano Management LLC0$00.00%−99,912−100.0%Sold out
Tri Locum Partners LP0$00.00%−77,048−100.0%Sold out
Pier Capital, LLC0$00.00%−76,066−100.0%Sold out
Moore Capital Management, LP0$00.00%−75,000−100.0%Sold out
Lombard Odier Asset Management (Switzerland) SA0$00.00%−71,180−100.0%Sold out
DAFNA Capital Management LLC0$00.00%−57,746−100.0%Sold out
Mirae Asset Global Investments Co., Ltd.0$00.00%−50,462−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−50,000−100.0%Sold out
Parkman Healthcare Partners LLC0$00.00%−25,000−100.0%Sold out
EFG Asset Management (North America) Corp.0$00.00%−24,031−100.0%Sold out
Monashee Investment Management LLC0$00.00%−21,259−100.0%Sold out
HSBC Holdings PLC0$00.00%−17,530−100.0%Sold out
Panagora Asset Management Inc0$00.00%−16,231−100.0%Sold out
Natixis0$00.00%−15,700−100.0%Sold out
Keybank National Association0$00.00%−8,373−100.0%Sold out
Ameritas Investment Partners, Inc.0$00.00%−7,386−100.0%Sold out
Wolverine Trading, LLC0$00.00%−5,966−100.0%Sold out
Metropolitan Life Insurance Co0$00.00%−5,066−100.0%Sold out
Nebula Research & Development LLC0$00.00%−4,821−100.0%Sold out
Cim Investment Mangement Inc0$00.00%−4,744−100.0%Sold out
Man Group plc0$00.00%–Sold out
Alberta Investment Management Corp0$00.00%−4,015−100.0%Sold out
Sandia Investment Management LP0$00.00%−4,000−100.0%Sold out
Union Investments & Development Ltd.0$00.00%−3,000−100.0%Sold out
Baillie Gifford & Co0$00.00%−325−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−308−100.0%Sold out
Belpointe Asset Management LLC0$00.00%−224−100.0%Sold out
Itau Unibanco Holding S.A.0$00.00%−179−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−116−100.0%Sold out
Parallax Volatility Advisers, L.P.0$00.00%−89−100.0%Sold out
Leonteq Securities AG0$00.00%−62−100.0%Sold out
Institutional & Family Asset Management, LLC0$00.00%−4−100.0%Sold out
Stonnington Group, LLC––––Not filed
Harvest Group Wealth Management, LLC––––Not filed